[1]常羽茜 李昱熙 刘旭 刘志浩 张岩.肾动脉狭窄介入治疗中的血流动力学评估进展[J].心血管病学进展,2024,(3):196.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.002]
　CHANG Yuxi,LI Yuxi,LIU Xu,et al.Hemodynamic Evaluation in Interventional Treatment of Renal Artery Stenosis[J].Advances in Cardiovascular Diseases,2024,(3):196.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.002]
点击复制

肾动脉狭窄介入治疗中的血流动力学评估进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2024年3期
页码:
196
栏目:
主题综述
出版日期:
2024-03-25

文章信息/Info

Title:
Hemodynamic Evaluation in Interventional Treatment of Renal Artery Stenosis
作者:
常羽茜 李昱熙 刘旭 刘志浩 张岩
(北京大学第一医院心内科,北京100034)
Author(s):
CHANG Yuxi; LI Yuxi; LIU Xu; LIU Zhihao; ZHANG Yan
(Department of Cardiology,Peking University First Hospital,Beijing 100034,China)
关键词:
肾动脉狭窄; 介入治疗; 血流动力学; 肾脏血流储备分数
Keywords:
Renal artery stenosis; Interventional therapy; Hemodynamics; Renal fractional flow reserve
DOI:
10.16806/j.cnki.issn.1004-3934.2024.03.002
摘要:
肾动脉狭窄是导致继发性高血压及肾功能不全的常见原因，介入治疗是重要的治疗方法之一。既往大规模随机对照研究表明，介入治疗相比单纯药物治疗可能无法为动脉粥样硬化相关肾动脉狭窄患者带来获益，但这些研究存在选择偏倚等缺陷，其结论引发了广泛争议。现主要探究肾动脉狭窄的血流动力学评估方法，总结血流动力学指导的介入治疗对患者预后的预测能力，并对血流动力学评估下介入治疗在肾动脉狭窄患者中的应用及发展做出展望。
Abstract:
Renal artery stenosis is a common cause of secondary hypertension and renal insufficiency, and interventional therapy is one of the important treatment methods. Previous large-scale randomized controlled trials have shown that interventional therapy may not bring benefit for patients with atherosclerotic renal artery stenosis compared to drug therapy alone , but the conclusion has caused wide debate due to the shortcomings in these studies such as selection bias. This article mainly explores the hemodynamic evaluation methods of renal artery stenosis , summarizes the ability of hemodynamic guided interventional therapy to predict the prognosis of patients , and makes prospects for the application and development of interventional therapy under hemodynamic evaluation in patients with renal artery stenosis.

参考文献/References:

[1] De Mast Q,Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups:a systematic literature review[J]. J Hypertens,2009,27(7):1333-1340.

[2] 中国医疗保健国际交流促进会血管疾病高血压分会专家共识起草组. 肾动脉狭窄的诊断和处理中国专家共识[J]. 中国循环杂志,2017,32(9):835-844.

[3] Parikh SA,Shishehbor MH,Gray BH,et al. SCAI expert consensus statement for renal artery stenting appropriate use[J]. Catheter Cardiovasc Interv,2014,84(7):1163-1171.

[4] Ritchie J,Green D,Chrysochou C,et al. High-risk clinical presentations in atherosclerotic renovascular disease:prognosis and response to renal artery revascularization[J]. Am J Kidney Dis,2014,63(2):186-197.

[5] Aboyans V,Ricco JB,Bartelink MEL,et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases,in collaboration with the European Society for Vascular Surgery (ESVS):Document covering atherosclerotic disease of extracranial carotid and vertebral,mesenteric,renal,upper and lower extremity arteriesEndorsed by:the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)[J]. Eur Heart J,2018,39(9):763-816.

[6] Evans KL,Tuttle KR,Folt DA,et al. Use of renin-angiotensin inhibitors in people with renal artery stenosis[J]. Clin J Am Soc Nephrol,2014,9(7):1199-206.

[7] Caps MT,Perissinotto C,Zierler RE,et al. Prospective study of atherosclerotic disease progression in the renal artery[J]. Circulation,1998,98(25):2866-2872.

[8] Moneta GL. Revascularization versus medical therapy for renal-artery stenosis[J]. Yearbook of Vascular Surgery,2010,2010:163-165.

[9] Cooper CJ,Murphy TP,Cutlip DE,et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis[J]. N Engl J Med,2014,370(1):13-22.

[10] Bax L,Woittiez AJ,Kouwenberg HJ,et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function:a randomized trial[J]. Ann Intern Med,2009,150(12):840-848,W150-W151.

[11] van de Ven PJ,Beutler JJ,Kaatee R,et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis[J]. Lancet,1995,346(8976):672-674.

[12] Harden PN,Macleod MJ,Rodger RS,et al. Effect of renal-artery stenting on progression of renovascular renal failure[J]. Lancet,1997,349(9059):1133-1136.

[13] White CJ,Ramee SR,Collins TJ,et al. Renal artery stent placement:utility in lesions difficult to treat with balloon angioplasty[J]. J Am Coll Cardiol,1997,30(6):1445-1450.

[14] Henry M,Amor M,Henry I,et al. Stent placement in the renal artery:three-year experience with the Palmaz stent[J]. J Vasc Interv Radiol,1996,7(3):343-350.

[15] Iannone LA,Underwood PL,Nath A,et al. Effect of primary balloon expandable renal artery stents on long-term patency,renal function,and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis[J]. Cathet Cardiovasc Diagn,1996,37(3):243-250.

[16] Kalra PA,Chrysochou C,Green D,et al. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease[J]. Catheter Cardiovasc Interv,2010,75(1):1-10.

[17] Gray BH,Olin JW,Childs MB,et al. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure[J]. Vasc Med,2002,7(4):275-279.

[18] Balk EM, Raman G, Adam GP, et al. Renal artery stenosis management strategies: an updated comparative effectiveness review[Internet][M]. Rockville (MD): Agency for Healthcare Research and Quality (US),2016,Report No.:16-EHC026-EF. PMID: 27583317.

[19] Van Brussel PM,Van De Hoef TP,De Winter RJ,et al. Hemodynamic measurements for?the?selection of patients with renal?artery?stenosis:a systematic review[J]. JACC Cardiovasc Interv,2017,10(10):973-985.

[20] Leesar MA,Varma J,Shapira A,et al. Prediction of hypertension improvement after stenting of renal artery stenosis:comparative accuracy of translesional pressure gradients,intravascular ultrasound,and angiography[J]. J Am Coll Cardiol,2009,53(25):2363-2371.

[21] Zeller T,Krankenberg H,Erglis A,et al. A randomized,multi-center,prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) - one-year results of a pre-maturely terminated study[J]. Trials,2017,18(1):380.

[22] Pijls NH,van Son JA,Kirkeeide RL,et al. Experimental basis of determining maximum coronary,myocardial,and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty[J]. Circulation,1993,87(4):1354-1367.

[23] 郭曦,李彭,刘光锐,等. 血流储备分数在肾动脉狭窄腔内修复术中的应用价值[J]. 中华心血管病杂志,2015,43(5):413-417.

[24] Levine GN,Bates ER,Blankenship JC,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J]. J Am Coll Cardiol,2011,58(24):e44-e122.

[25] Li J,Elrashidi MY,Flammer AJ,et al. Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice[J]. Eur Heart J,2013,34(18):1375-1383.

[26] Wilson RF,White CW. Intracoronary papaverine:an ideal coronary vasodilator for studies of the coronary circulation in conscious humans[J]. Circulation,1986,73(3):444-451.

[27] Beregi JP,Mounier-Vehier C,Devos P,et al. Doppler flow wire evaluation of renal blood flow reserve in hypertensive patients with normal renal arteries[J]. Cardiovasc Intervent Radiol,2000,23(5):340-346.

[28] Subramanian R,White CJ,Rosenfield K,et al. Renal fractional flow reserve:a hemodynamic evaluation of moderate renal artery stenoses[J]. Catheter Cardiovasc Interv,2005,64(4):480-486.

[29] Manoharan G,Pijls NH,Lameire N,et al. Assessment of renal flow and flow reserve in humans[J]. J Am Coll Cardiol,2006,47(3):620-625.

[30] Protasiewicz M,Pocz?tek K,Por?ba R,et al. Comparison of the renal hyperemic effects of papaverine and dopamine in patients with renal artery stenosis[J]. J Am Soc Hypertens,2015,9(1):9-14.

[31] Mangiacapra F,Trana C,Sarno G,et al. Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension[J]. Circ Cardiovasc Interv,2010,3(6):537-542.

[32] Jones NJ,Bates ER,Chetcuti SJ,et al. Usefulness of translesional pressure gradient and pharmacological provocation for the assessment of intermediate renal artery disease[J]. Catheter Cardiovasc Interv,2006,68(3):429-434.

[33] Gross CM,Kr?mer J,Weing?rtner O,et al. Determination of renal arterial stenosis severity:comparison of pressure gradient and vessel diameter[J]. Radiology,2001,220(3):751-756.

[34] Kadziela J,Witkowski A,Januszewicz A,et al. Assessment of renal artery stenosis using both resting pressures ratio and fractional flow reserve:relationship to angiography and ultrasonography[J]. Blood Press,2011,20(4):211-2117.

[35] Kawarada O,Yokoi Y,Takemoto K,et al. The performance of renal duplex ultrasonography for the detection of hemodynamically significant renal artery stenosis[J]. Catheter Cardiovasc Interv,2006,68(2):311-318.

[36] Staub D,Canevascini R,Huegli RW,et al. Best duplex-sonographic criteria for the assessment of renal artery stenosis—Correlation with intra- arterial pressure gradient[J]. Ultraschall Med,2007,28(1):45-51.

[37] Drieghe B,Madaric J,Sarno G,et al. Assessment of renal artery stenosis:side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements[J]. Eur Heart J,2008,29(4):517-524.

[38] Loutzenhiser R,Griffin K,Williamson G,et al. Renal autoregulation:new perspectives regarding the protective and regulatory roles of the underlying mechanisms[J]. Am J Physiol Regul Integr Comp Physiol,2006,290(5):R1153-R1167.

[39] Mitchell JA,Subramanian R,White CJ,et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement:renal fractional flow reserve[J]. Catheter Cardiovasc Interv,2007,69(5):685-689.

[40] K?dziela J,Januszewicz A,Prejbisz A,et al. Prognostic value of renal fractional flow reserve in blood pressure response after renal artery stenting (PREFER study)[J]. Cardiol J,2013,20(4):418-422.

[41] K?dziela J,Prejbisz A,Micha?owska I,et al. Relationship between hemodynamic parameters of renal artery stenosis and the changes of kidney function after renal artery stenting in patients with hypertension and preserved renal function[J]. Blood Press,2015,24(1):30-34.

[42] Li Y,Wen X,Zheng B,et al. Case report:combination of pressure guidewire and optical coherence tomography-guided drug-coated balloon revascularization for renal artery fibromuscular dysplasia[J]. Front Cardiovasc Med,2021,8:773563.

[43] 何志裕,罗碧辉,陈爱兰,等. 血流储备分数在肾动脉支架植入术中治疗肾动脉狭窄患者的应用价值[J]. 岭南心血管病杂志,2022,28(5):385-390.

[44] Protasiewicz M,K?dziela J,Pocz?tek K,et al. Renal artery stenosis in patients with resistant hypertension[J]. Am J Cardiol,2013,112(9):1417-1420.

[45] Fearon WF,Low AF,Yong AS,et al. Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention[J]. Circulation,2013,127(24):2436-2441.

相似文献/References:

[1]左鹏程 莫绪明.婴幼儿主动脉缩窄术后再狭窄的诊疗进展[J].心血管病学进展,2021,(3):216.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.006]
　ZUO Pengcheng,MO Xuming.Diagnosis and Treatment of Restenosis after Aortic Coarctation in Infants[J].Advances in Cardiovascular Diseases,2021,(3):216.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.006]
[2]龚勇泉?农巍?吴先球?卢天成?韦成信.弓部受累的主动脉病变治疗应用进展[J].心血管病学进展,2023,(7):658.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.019]
　GONG Yongquan,NONG Wei,WU Xianqiu,et al.Treatment of Aortic Diseases Involving Arch[J].Advances in Cardiovascular Diseases,2023,(3):658.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.019]
[3]胡雪梅 胥雪莲 唐炯.血管迷走性晕厥介入治疗的研究进展[J].心血管病学进展,2023,(8):690.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.005]
　HU Xuemei,XU Xuelian,TANG Jiong.Interventional Therapy of Vasovagal Syncope[J].Advances in Cardiovascular Diseases,2023,(3):690.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.005]
[4]董震宇 穆耶赛尔·玉苏普 芦颜美 汤宝鹏.介入器械治疗慢性心力衰竭的研究进展[J].心血管病学进展,2023,(12):1061.[doi:10. 16806/j. cnki. issn. 1004-3934. 2023. 12. 002]
　DONG Zhenyu,Muyassar·Yusup,LU Yanmei,et al.Device-based Interventional Strategies for Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2023,(3):1061.[doi:10. 16806/j. cnki. issn. 1004-3934. 2023. 12. 002]
[5]徐克 孙阳 汪道文.梗阻性肥厚型心肌病的介入和外科手术治疗及进展[J].心血管病学进展,2024,(2):103.[doi:10.16806/j.cnki.issn.1004-3934.2024.02.000]
　XU Ke,SUN Yang,WANG Daowen?/html>.New Perspectives on Interventional and Surgical Treatment for?bstructive Hypertrophic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2024,(3):103.[doi:10.16806/j.cnki.issn.1004-3934.2024.02.000]
[6]李建平 李昱熙.肾动脉与高血压[J].心血管病学进展,2024,(3):193.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.001]
　LI Jianping,LI Yuxi.Renal Artery and Hypertension[J].Advances in Cardiovascular Diseases,2024,(3):193.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.001]
[7]林志勇 邱建星.影像学在肾血管性高血压评估中的进展[J].心血管病学进展,2024,(3):201.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.003]
　LIN Zhiyong,QIU Jianxing.Imaging Assessment of Renovascular Hypertension[J].Advances in Cardiovascular Diseases,2024,(3):201.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.003]

更新日期/Last Update: 2024-04-26